Growth hormone signaling in pancreatic β-cells-Calcium handling regulated by growth hormone

Molecular and Cellular Endocrinology

Volumn 297, Issue 1-2, 2009, Pages 50-57

  Zhang, Fan ^a   Sjöholm, Åke ^a   Zhang, Qimin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Ca2+ induced Ca2+ release; Growth hormone; Growth hormone receptor; Insulin; Prolactin receptor; Tyrosine kinase

Indexed keywords

CALCIUM ION; GROWTH HORMONE RECEPTOR; HUMAN GROWTH HORMONE; INSULIN; JANUS KINASE 2; PROLACTIN RECEPTOR; PROTEIN TYROSINE KINASE; RYANODINE RECEPTOR; VOLTAGE GATED CALCIUM CHANNEL;

CALCIUM TRANSPORT; CELL ACTIVATION; CELL FUNCTION; CELL PROLIFERATION; ENZYME ACTIVATION; EXTRACELLULAR CALCIUM; HUMAN; INSULIN RELEASE; MEMBRANE POTENTIAL; MITOGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; GROWTH HORMONE; HUMANS; INSULIN-SECRETING CELLS; INTRACELLULAR SPACE; RECEPTORS, SOMATOTROPIN; SIGNAL TRANSDUCTION;

EID: 57649230850     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.06.001     Document Type: Review

References (118)

1. Abdul-Ghani M.A., Tripathy D., and DeFronzo R.A. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29 5 (2006) 1130-1139
2. al-Sakkaf K.A., Dobson P.R., and Brown B.L. Prolactin induced tyrosine phosphorylation of p59fyn may mediate phosphatidylinositol 3-kinase activation in Nb2 cells. J. Mol. Endocrinol. 19 3 (1997) 347-350
3. Al-Sakkaf K.A., Mooney L.M., Dobson P.R., and Brown B.L. Possible role for protein kinase B in the anti-apoptotic effect of prolactin in rat Nb2 lymphoma cells. J. Endocrinol. 167 1 (2000) 85-92
4. Ammala C., Eliasson L., Bokvist K., Berggren P.O., Honkanen R.E., Sjoholm A., and Rorsman P. Activation of protein kinases and inhibition of protein phosphatases play a central role in the regulation of exocytosis in mouse pancreatic beta cells. Proc. Natl. Acad. Sci. U.S.A. 91 10 (1994) 4343-4347
5. Argetsinger L.S., Campbell G.S., Yang X., Witthuhn B.A., Silvennoinen O., Ihle J.N., and Carter-Su C. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74 2 (1993) 237-244
6. Ashcroft S.J. Protein phosphorylation and beta-cell function. Diabetologia 37 Suppl. 2 (1994) S21-S29
7. Banhegyi G., Baumeister P., Benedetti A., Dong D., Fu Y., Lee A.S., Li J., Mao C., Margittai E., Ni M., Paschen W., Piccirella S., Senesi S., Sitia R., Wang M., and Yang W. Endoplasmic reticulum stress. Ann. N. Y. Acad. Sci. 1113 (2007) 58-71
8. Bell G.I., and Polonsky K.S. Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 414 6865 (2001) 788-791
9. Berlanga J.J., Fresno Vara J.A., Martin-Perez J., and Garcia-Ruiz J.P. Prolactin receptor is associated with c-src kinase in rat liver. Mol. Endocrinol. 9 11 (1995) 1461-1467
10. Bezprozvanny I., Watras J., and Ehrlich B.E. Bell-shaped calcium-response curves of Ins(1,4,5)P3- and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature 351 6329 (1991) 751-754
11. 2+ oscillations and gene transcription. Proc. Natl. Acad. Sci. U.S.A. 92 7 (1995) 2725-2729
12. Billestrup N., and Nielsen J.H. The stimulatory effect of growth hormone, prolactin, and placental lactogen on beta-cell proliferation is not mediated by insulin-like growth factor-I. Endocrinology 129 2 (1991) 883-888
13. Bjorge J.D., Jakymiw A., and Fujita D.J. Selected glimpses into the activation and function of Src kinase. Oncogene 19 49 (2000) 5620-5635
14. Bonner-Weir S. Life and death of the pancreatic beta cells. Trends Endocrinol. Metab. 11 9 (2000) 375-378
15. Bonner-Weir S. Perspective: postnatal pancreatic beta cell growth. Endocrinology 141 6 (2000) 1926-1929
16. i increases in Chinese hamster ovary cells. Mol. Cell Endocrinol. 131 1 (1997) 109-120
17. Brelje T.C., and Sorenson R.L. Role of prolactin versus growth hormone on islet B-cell proliferation in vitro: implications for pregnancy. Endocrinology 128 1 (1991) 45-57
18. Carter-Su C., Argetsinger L.S., Campbell G.S., Wang X., Ihle J., and Witthuhn B. The identification of JAK2 tyrosine kinase as a signaling molecule for growth hormone. Proc. Soc. Exp. Biol. Med. 206 3 (1994) 210-215
19. Clevenger C.V., and Medaglia M.V. The protein tyrosine kinase P59fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T-lymphocytes. Mol. Endocrinol. 8 6 (1994) 674-681
20. da Silva C.P., and Guse A.H. Intracellular Ca(2+) release mechanisms: multiple pathways having multiple functions within the same cell type?. Biochim. Biophys. Acta 1498 2-3 (2000) 122-133
21. Davies G.F., Khandelwal R.L., Wu L., Juurlink B.H., and Roesler W.J. Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism. Biochem. Pharmacol. 62 8 (2001) 1071-1079
22. Dickson L.M., and Rhodes C.J. Pancreatic beta-cell growth and survival in the onset of type 2 diabetes: a role for protein kinase B in the Akt?. Am. J. Physiol. Endocrinol. Metab. 287 2 (2004) E192-E198
23. Doglio A., Dani C., Grimaldi P., and Ailhaud G. Growth hormone stimulates c-fos gene expression by means of protein kinase C without increasing inositol lipid turnover. Proc. Natl. Acad. Sci. U.S.A. 86 4 (1989) 1148-1152
24. Dominici F.P., Argentino D.P., Munoz M.C., Miquet J.G., Sotelo A.I., and Turyn D. Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity. Growth Horm. IGF Res. 15 5 (2005) 324-336
25. Dyachok O., and Gylfe E. Ca(2+)-induced Ca(2+) release via inositol 1,4,5-trisphosphate receptors is amplified by protein kinase A and triggers exocytosis in pancreatic beta-cells. J. Biol. Chem. 279 44 (2004) 45455-45461
26. Feng J., Witthuhn B.A., Matsuda T., Kohlhuber F., Kerr I.M., and Ihle J.N. Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Mol. Cell Biol. 17 5 (1997) 2497-2501
27. Fernandez A.M., Kim J.K., Yakar S., Dupont J., Hernandez-Sanchez C., Castle A.L., Filmore J., Shulman G.I., and Le Roith D. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev. 15 15 (2001) 1926-1934
28. Flores-Morales A., Greenhalgh C.J., Norstedt G., and Rico-Bautista E. Negative regulation of growth hormone receptor signaling. Mol. Endocrinol. 20 2 (2006) 241-253
29. Foster C.M., Shafer J.A., Rozsa F.W., Wang X.Y., Lewis S.D., Renken D.A., Natale J.E., Schwartz J., and Carter-Su C. Growth hormone promoted tyrosyl phosphorylation of growth hormone receptors in murine 3T3-F442A fibroblasts and adipocytes. Biochemistry 27 1 (1988) 326-334
30. Freemark M., Avril I., Fleenor D., Driscoll P., Petro A., Opara E., Kendall W., Oden J., Bridges S., Binart N., Breant B., and Kelly P.A. Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance. Endocrinology 143 4 (2002) 1378-1385
31. Furuichi T., Yoshikawa S., Miyawaki A., Wada K., Maeda N., and Mikoshiba K. Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400. Nature 342 6245 (1989) 32-38
32. Garay G.L., Akerblom H.K., and Martin J.M. Experimental hypersomatotropism: serum growth hormone and insulin, and pituitary and pancreatic changes in MtT-W15 tumor-bearing rats before and after tumor removal. Horm. Metab. Res. 3 2 (1971) 82-89
33. Gaur S., Yamaguchi H., and Goodman H.M. Growth hormone regulates cytosolic free calcium in rat fat cells by maintaining L-type calcium channels. Am. J. Physiol. 270 5 Pt 1 (1996) C1478-C1484
34. Gloyn A.L., Weedon M.N., Owen K.R., Turner M.J., Knight B.A., Hitman G., Walker M., Levy J.C., Sampson M., Halford S., McCarthy M.I., Hattersley A.T., and Frayling T.M. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52 2 (2003) 568-572
35. Goodarzi M.O., Lehman D.M., Taylor K.D., Guo X., Cui J., Quinones M.J., Clee S.M., Yandell B.S., Blangero J., Hsueh W.A., Attie A.D., Stern M.P., and Rotter J.I. SORCS1: a novel human type 2 diabetes susceptibility gene suggested by the mouse. Diabetes 56 7 (2007) 1922-1929
36. Graves T.K., and Hinkle P.M. Ca(2+)-induced Ca(2+) release in the pancreatic beta-cell: direct evidence of endoplasmic reticulum Ca(2+) release. Endocrinology 144 8 (2003) 3565-3574
37. Gu F., Dube N., Kim J.W., Cheng A., Ibarra-Sanchez Mde J., Tremblay M.L., and Boisclair Y.R. Protein tyrosine phosphatase 1B attenuates growth hormone-mediated JAK2-STAT signaling. Mol. Cell Biol. 23 11 (2003) 3753-3762
38. Guo Y., Lu Y., Houle D., Robertson K., Tang Z., Kopchick J.J., Liu Y.L., and Liu J.L. Pancreatic islet-specific expression of an insulin-like growth factor-I transgene compensates islet cell growth in growth hormone receptor gene-deficient mice. Endocrinology 146 6 (2005) 2602-2609
39. Guse A.H., Tsygankov A.Y., Weber K., and Mayr G.W. Transient tyrosine phosphorylation of human ryanodine receptor upon T cell stimulation. J. Biol. Chem. 276 37 (2001) 34722-34727
40. Hellerstrom C., Sjoholm A., and Swenne I. Effects of growth hormone and related growth factors on DNA replication and insulin production in pancreatic islet beta-cells. Acta Paediatr. Scand. Suppl. 377 (1991) 55-62 discussion 63
41. Hellman B., and Angervall L. The frequency distribution of the number and volume of the islets of Langerhans in man. 3. Studies in diabetes of early onset, insuloma and acromegaly. Acta Pathol. Microbiol. Scand. 53 (1961) 230-236
42. 2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37). J. Biol. Chem. 274 20 (1999) 14147-14156
43. Islam M.S. The ryanodine receptor calcium channel of beta-cells: molecular regulation and physiological significance. Diabetes 51 5 (2002) 1299-1309
44. Johnson R.M., Napier M.A., Cronin M.J., and King K.L. Growth hormone stimulates the formation of sn-1,2-diacylglycerol in rat hepatocytes. Endocrinology 127 5 (1990) 2099-2103
45. Johnston J.A., Kawamura M., Kirken R.A., Chen Y.Q., Blake T.B., Shibuya K., Ortaldo J.R., McVicar D.W., and O'Shea J.J. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370 6485 (1994) 151-153
46. Kahn S.E., and Halban P.A. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes 46 11 (1997) 1725-1732
47. Kahn S.E., Leonetti D.L., Prigeon R.L., Boyko E.J., Bergstrom R.W., and Fujimoto W.Y. Relationship of proinsulin and insulin with noninsulin-dependent diabetes mellitus and coronary heart disease in Japanese-American men: impact of obesity-clinical research center study. J. Clin. Endocrinol. Metab. 80 4 (1995) 1399-1406
48. 2+ release in INS-1 pancreatic beta-cells. J. Physiol. 536 Pt 2 (2001) 375-385
49. 2+ release in mouse pancreatic beta cells. J. Physiol. 566 Pt 1 (2005) 173-188
50. 2+ release in INS-1 pancreatic beta cells. J. Physiol. 546 Pt 1 (2003) 175-189
51. 2+ channels in pancreatic beta-cells. J. Biol. Chem. 276 13 (2001) 9971-9977
52. Lindberg K., Ronn S.G., Tornehave D., Richter H., Hansen J.A., Romer J., Jackerott M., and Billestrup N. Regulation of pancreatic beta-cell mass and proliferation by SOCS-3. J. Mol. Endocrinol. 35 2 (2005) 231-243
53. Lingohr M.K., Buettner R., and Rhodes C.J. Pancreatic beta-cell growth and survival-a role in obesity-linked type 2 diabetes?. Trends Mol. Med. 8 8 (2002) 375-384
54. Lis J., and Wu C. Protein traffic on the heat shock promoter: parking, stalling, and trucking along. Cell 74 1 (1993) 1-4
55. Liu J.L., Coschigano K.T., Robertson K., Lipsett M., Guo Y., Kopchick J.J., Kumar U., and Liu Y.L. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am. J. Physiol. Endocrinol. Metab. 287 3. (2004) E405-E413
56. Loos R.J., Franks P.W., Francis R.W., Barroso I., Gribble F.M., Savage D.B., Ong K.K., O'Rahilly S., and Wareham N.J. TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population. Diabetes 56 7 (2007) 1943-1947
57. Lu Y., Herrera P.L., Guo Y., Sun D., Tang Z., LeRoith D., and Liu J.L. Pancreatic-specific inactivation of IGF-I gene causes enlarged pancreatic islets and significant resistance to diabetes. Diabetes 53 12 (2004) 3131-3141
58. 2+-release channel function. Biochem. J. 337 Pt 3 (1999) 345-361
59. Maranto A.R. Primary structure, ligand binding, and localization of the human type 3 inositol 1,4,5-trisphosphate receptor expressed in intestinal epithelium. J. Biol. Chem. 269 2 (1994) 1222-1230
60. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., and Marks A.R. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101 4 (2000) 365-376
61. Masumiya H., Li P., Zhang L., and Chen S.R. Ryanodine sensitizes the Ca(2+) release channel (ryanodine receptor) to Ca(2+) activation. J. Biol. Chem. 276 43 (2001) 39727-39735
62. Meissner G. Regulation of mammalian ryanodine receptors. Front. Biosci. 7 (2002) d2072-d2080
63. 2+ release from insulin-containing vesicles in living pancreatic beta-cells (MIN6). J. Biol. Chem. 278 13 (2003) 11057-11064
64. Mitchell K.J., Pinton P., Varadi A., Tacchetti C., Ainscow E.K., Pozzan T., Rizzuto R., and Rutter G.A. Dense core secretory vesicles revealed as a dynamic Ca(2+) store in neuroendocrine cells with a vesicle-associated membrane protein aequorin chimaera. J. Cell Biol. 155 1 (2001) 41-51
65. Mizuno A., Arai H., Fukaya M., Sato M., Hisami Y.O., Takeda E., and Doi T. Early-phase insulin secretion is disturbed in obese subjects with glucose intolerance. Metabolism 56 6 (2007) 856-862
66. Moldrup A., Allevato G., Dyrberg T., Nielsen J.H., and Billestrup N. Growth hormone action in rat insulinoma cells expressing truncated growth hormone receptors. J. Biol. Chem. 266 26 (1991) 17441-17445
67. Moldrup A., Billestrup N., and Nielsen J.H. Rat insulinoma cells express both a 115-kDa growth hormone receptor and a 95-kDa prolactin receptor structurally related to the hepatic receptors. J. Biol. Chem. 265 15 (1990) 8686-8690
68. Moosmang S., Lenhardt P., Haider N., Hofmann F., and Wegener J.W. Mouse models to study L-type calcium channel function. Pharmacol. Ther. 106 3 (2005) 347-355
69. Moutoussamy S., Kelly P.A., and Finidori J. Growth-hormone-receptor and cytokine-receptor-family signaling. Eur. J. Biochem. 255 1 (1998) 1-11
70. 2+ channels. Proc. Natl. Acad. Sci. U.S.A. 102 31 (2005) 11112-11117
71. Neubauer H., Cumano A., Muller M., Wu H., Huffstadt U., and Pfeffer K. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 93 3 (1998) 397-409
72. Nielsen J.H., Galsgaard E.D., Moldrup A., Friedrichsen B.N., Billestrup N., Hansen J.A., Lee Y.C., and Carlsson C. Regulation of beta-cell mass by hormones and growth factors. Diabetes 50 Suppl. 1 (2001) S25-S29
73. Nielsen J.H., Linde S., Welinder B.S., Billestrup N., and Madsen O.D. Growth hormone is a growth factor for the differentiated pancreatic beta-cell. Mol. Endocrinol. 3 1 (1989) 165-173
74. Nielsen J.H., Moldrup A., and Billestrup N. Expression of the growth hormone receptor gene in insulin producing cells. Biomed. Biochim. Acta 49 12 (1990) 1151-1155
75. Okuda Y., Pena J., Chou J., and Field J.B. Acute effects of growth hormone on metabolism of pancreatic hormones, glucose and ketone bodies. Diabetes Res. Clin. Pract. 53 1 (2001) 1-8
76. Parganas E., Wang D., Stravopodis D., Topham D.J., Marine J.C., Teglund S., Vanin E.F., Bodner S., Colamonici O.R., van Deursen J.M., Grosveld G., and Ihle J.N. Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93 3 (1998) 385-395
77. Parnaud G., Bosco D., Berney T., Pattou F., Kerr-Conte J., Donath M.Y., Bruun C., Mandrup-Poulsen T., Billestrup N., and Halban P.A. Proliferation of sorted human and rat beta cells. Diabetologia 51 1 (2008) 91-100
78. Parsons J.A., Bartke A., and Sorenson R.L. Number and size of islets of Langerhans in pregnant, human growth hormone-expressing transgenic, and pituitary dwarf mice: effect of lactogenic hormones. Endocrinology 136 5 (1995) 2013-2021
79. Parsons J.A., Hartfel M.A., Hegre O.D., and McEvoy R.C. Effect of MtTW15 mammosomatotropic tumors on pancreatic islet hormones. Diabetes 32 1 (1983) 67-74
80. Pasquali C., Curchod M.L., Walchli S., Espanel X., Guerrier M., Arigoni F., Strous G., and Van Huijsduijnen R.H. Identification of protein tyrosine phosphatases with specificity for the ligand-activated growth hormone receptor. Mol. Endocrinol. 17 11 (2003) 2228-2239
81. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., Landaker E.J., Goldfine A.B., Mun E., DeFronzo R., Finlayson J., Kahn C.R., and Mandarino L.J. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. U.S.A. 100 14 (2003) 8466-8471
82. Pick A., Clark J., Kubstrup C., Levisetti M., Pugh W., Bonner-Weir S., and Polonsky K.S. Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat. Diabetes 47 3 (1998) 358-364
83. Porksen N. The in vivo regulation of pulsatile insulin secretion. Diabetologia 45 1 (2002) 3-20
84. Prevarskaya N.B., Skryma R.N., Vacher P., Daniel N., Djiane J., and Dufy B. Role of tyrosine phosphorylation in potassium channel activation. Functional association with prolactin receptor and JAK2 tyrosine kinase. J. Biol. Chem. 270 41 (1995) 24292-24299
85. Ram P.A., and Waxman D.J. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase. J. Biol. Chem. 272 28 (1997) 17694-17702
86. Rhodes C.J. IGF-I and GH post-receptor signaling mechanisms for pancreatic beta-cell replication. J. Mol. Endocrinol. 24 3 (2000) 303-311
87. Rozengurt E. Early signals in the mitogenic response. Science 234 4773 (1986) 161-166
88. Sandberg E.M., Ma X., He K., Frank S.J., Ostrov D.A., and Sayeski P.P. Identification of 1,2,3,4,5,6-hexabromocyclohexane as a small molecule inhibitor of jak2 tyrosine kinase autophosphorylation [correction of autophophorylation]. J. Med. Chem. 48 7 (2005) 2526-2533
89. Schwartz Y., Yamaguchi H., and Goodman H.M. Growth hormone increases intracellular free calcium in rat adipocytes: correlation with actions on carbohydrate metabolism. Endocrinology 131 2 (1992) 772-778
90. Sekine N., Ullrich S., Regazzi R., Pralong W.F., and Wollheim C.B. Postreceptor signalling of growth hormone and prolactin and their effects in the differentiated insulin-secreting cell line, INS-1. Endocrinology 137 5 (1996) 1841-1850
91. Sencer S., Papineni R.V., Halling D.B., Pate P., Krol J., Zhang J.Z., and Hamilton S.L. Coupling of RYR1 and L-type calcium channels via calmodulin binding domains. J. Biol. Chem. 276 41 (2001) 38237-38241
92. Sesti G. Apoptosis in the beta cells: cause or consequence of insulin secretion defect in diabetes?. Ann. Med. 34 6 (2002) 444-450
93. Silva C.M., Day R.N., Weber M.J., and Thorner M.O. Human growth hormone (GH) receptor is characterized as the 134-kilodalton tyrosine-phosphorylated protein activated by GH treatment in IM-9 cells. Endocrinology 133 5 (1993) 2307-2312
94. Sirotkin A.V. Control of reproductive processes by growth hormone: extra- and intracellular mechanisms. Vet. J. 170 3 (2005) 307-317
95. Sirotkin A.V., and Makarevich A.V. GH regulates secretory activity and apoptosis in cultured bovine granulosa cells through the activation of the cAMP/protein kinase A system. J. Endocrinol. 163 2 (1999) 317-327
96. Sirotkin A.V., and Makarevich A.V. Growth hormone can regulate functions of porcine ovarian granulosa cells through the cAMP/protein kinase A system. Anim. Reprod. Sci. 70 1-2 (2002) 111-126
97. Sjoholm A. Diabetes mellitus and impaired pancreatic beta-cell proliferation. J. Intern. Med. 239 3 (1996) 211-220
98. 2+ influx and diacylglycerol synthesis in growth hormone-mediated islet beta-cell mitogenesis. J. Biol. Chem. 275 28 (2000) 21033-21040
99. Smal J., and De Meyts P. Sphingosine, an inhibitor of protein kinase C, suppresses the insulin-like effects of growth hormone in rat adipocytes. Proc. Natl. Acad. Sci. U.S.A. 86 12 (1989) 4705-4709
100. Smit L.S., Meyer D.J., Billestrup N., Norstedt G., Schwartz J., and Carter-Su C. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1,3 and 5 by GH. Mol. Endocrinol. 10 5 (1996) 519-533
101. Sneyd J., and Falcke M. Models of the inositol trisphosphate receptor. Prog. Biophys. Mol. Biol. 89 3 (2005) 207-245
102. Sorin B., Vacher A.M., Djiane J., and Vacher P. Role of protein kinases in the prolactin-induced intracellular calcium rise in Chinese hamster ovary cells expressing the prolactin receptor. J. Neuroendocrinol. 12 9 (2000) 910-918
103. Stofega M.R., Herrington J., Billestrup N., and Carter-Su C. Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B. Mol. Endocrinol. 14 9 (2000) 1338-1350
104. Stofega M.R., Wang H., Ullrich A., and Carter-Su C. Growth hormone regulation of SIRP and SHP-2 tyrosyl phosphorylation and association. J. Biol. Chem. 273 12 (1998) 7112-7117
105. Sudhof T.C., Newton C.L., Archer III B.T., Ushkaryov Y.A., and Mignery G.A. Structure of a novel InsP3 receptor. EMBO J. 10 11 (1991) 3199-3206
106. Suko J., Maurer-Fogy I., Plank B., Bertel O., Wyskovsky W., Hohenegger M., and Hellmann G. Phosphorylation of serine 2843 in ryanodine receptor-calcium release channel of skeletal muscle by cAMP-, cGMP- and CaM-dependent protein kinase. Biochim. Biophys. Acta 1175 2 (1993) 193-206
107. 2+ release channels: does diversity in form equal diversity in function?. Physiol. Rev. 76 4 (1996) 1027-1071
108. Tam S.P., Lau P., Djiane J., Hilton D.J., and Waters M.J. Tissue-specific induction of SOCS gene expression by PRL. Endocrinology 142 11 (2001) 5015-5026
109. Wang G.L., Shi X., Salisbury E., Sun Y., Albrecht J.H., Smith R.G., and Timchenko N.A. Growth hormone corrects proliferation and transcription of phosphoenolpyruvate carboxykinase in livers of old mice via elimination of CCAAT/enhancer-binding protein alpha-Brm complex. J. Biol. Chem. 282 2 (2007) 1468-1478
110. Waters M.J., Hoang H.N., Fairlie D.P., Pelekanos R.A., and Brown R.J. New insights into growth hormone action. J. Mol. Endocrinol. 36 1 (2006) 1-7
111. Weinhaus A.J., Stout L.E., and Sorenson R.L. Glucokinase, hexokinase, glucose transporter 2, and glucose metabolism in islets during pregnancy and prolactin-treated islets in vitro: mechanisms for long term up-regulation of islets. Endocrinology 137 5 (1996) 1640-1649
112. Weir G.C., Laybutt D.R., Kaneto H., Bonner-Weir S., and Sharma A. Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes 50 Suppl. 1 (2001) S154-S159
113. Yakar S., Liu J.L., Fernandez A.M., Wu Y., Schally A.V., Frystyk J., Chernausek S.D., Mejia W., and Le Roith D. Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes 50 5 (2001) 1110-1118
114. Yip R.G., and Goodman H.M. Growth hormone and dexamethasone stimulate lipolysis and activate adenylyl cyclase in rat adipocytes by selectively shifting Gi alpha2 to lower density membrane fractions. Endocrinology 140 3 (1999) 1219-1227
115. Yoshida A., Ogura A., Imagawa T., Shigekawa M., and Takahashi M. Cyclic AMP-dependent phosphorylation of the rat brain ryanodine receptor. J. Neurosci. 12 3 (1992) 1094-1100
116. 2+ and insulin secretion. Am. J. Physiol. Cell Physiol. 291 3 (2006) C466-C475
117. Zhang Q., Kohler M., Yang S.N., Zhang F., Larsson O., and Berggren P.O. Growth hormone promotes Ca(2+)-induced Ca2+ release in insulin-secreting cells by ryanodine receptor tyrosine phosphorylation. Mol. Endocrinol. 18 7 (2004) 1658-1669
118. Zhu T., Goh E.L., LeRoith D., and Lobie P.E. Growth hormone stimulates the formation of a multiprotein signaling complex involving p130(Cas) and CrkII. Resultant activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK). J. Biol. Chem. 273 50 (1998) 33864-33875